GSK Sweetens Early-Stage Diabetes Pipeline With HGS’ Albugon
This article was originally published in The Pink Sheet Daily
Executive Summary
The preclinical peptide hormone will likely be developed for Type-2 diabetes. Human Genome Sciences believes potential advantage with Albugon is prolonged half-life.